Kelly Whitehead
Family · Jennings, LANPI 1801442405
Payments from drug & device makers
Across 97 payments — averaging $19.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$684
- Novo Nordisk$142
- Lilly USA, LLC$131
- Esperion Therapeutics, Inc.$111
- Ardelyx, Inc.$88
- AstraZeneca$72
- plus $634 from 17 others
What the payments were for
- Food & beverage$1,863100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 43 | $684 |
| Novo Nordisk | 4 | $142 |
| Lilly USA, LLC | 7 | $131 |
| Esperion Therapeutics, Inc. | 1 | $111 |
| Ardelyx, Inc. | 4 | $88 |
| AstraZeneca | 5 | $72 |
| Alkermes, Inc. | 3 | $68 |
| Bard Peripheral Vascular, Inc. | 1 | $62 |
| Novartis | 3 | $62 |
| Pfizer | 3 | $57 |
| Otsuka America Pharmaceutical, Inc. | 3 | $45 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $43 |
| Exact Sciences | 2 | $40 |
| Amgen | 3 | $40 |
| Indivior Inc. | 2 | $38 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $36 |
| Astellas Pharma US Inc | 2 | $36 |
| Merck | 2 | $31 |
| GSK | 1 | $20 |
| Boehringer Ingelheim | 1 | $17 |
| Genentech USA, Inc. | 1 | $16 |
| Sanofi-aventis U.S. LLC | 1 | $13 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,863 in reported general payments places this provider in the 75th percentile of 3,610 family providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MounjaroTirzepatide | 101 | $107,548 |
| OzempicSemaglutide | 62 | $65,306 |
| FarxigaDapagliflozin Propanediol | 39 | $49,085 |
| LinzessLinaclotide | 20 | $12,198 |
| TrintellixVortioxetine Hydrobromide | 17 | $11,549 |
| EliquisApixaban | 15 | $11,516 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $5,384 |
| Dexlansoprazole DrDexlansoprazole | 19 | $4,153 |
| VascepaIcosapent Ethyl | 14 | $2,408 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 55 | $1,435 |
| Diclofenac Sodium | 32 | $1,181 |
| Rosuvastatin Calcium | 73 | $739 |
| Duloxetine Hcl | 45 | $654 |
| ValacyclovirValacyclovir Hcl | 15 | $621 |
| Gabapentin | 33 | $489 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCMounjaro | $131 | $107,548101 claims |
| Novo NordiskOzempic | $142 | $65,30662 claims |
| AstraZenecaFarxiga | $72 | $49,08539 claims |
| AbbVieLinzess | $684 | $12,19820 claims |
| Takeda Pharmaceuticals U.S.A., Inc.Trintellix | $12 | $11,54917 claims |
| PfizerEliquis | $57 | $11,51615 claims |
| GSKAnoro Ellipta | $20 | $5,38411 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 3,610 family providers in Louisiana.
Other family in Jennings
- Rebecca EzellSlidell$268K
- Erin PierceNew Orleans$261K
- Tavell KindallNew Orleans$194K
- Ashlea HillRuston$169K
- Brittany MillerVille Platte$158K
- Ryanne ClarkeGretna$123K
- Elidia DewittBaton Rouge$108K
- Rebekah GarrardLafayette$105K
- Tiffany RoeShreveport$97K
- Ghenet GhebretatiosBaton Rouge$91K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.